AFLAC Incorporated (AFL) reported quarterly earnings results on Tuesday, Apr-26-2016. The company said it had a profit of $1.74 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.11. Analysts had a consensus of $1.63. The company posted revenue of $5451.00 million in the period, compared to analysts expectations of $5287.72 million. The company’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.54 EPS.
Many Wall Street Analysts have commented on AFLAC Incorporated. AFLAC Incorporated was Downgraded by Raymond James to ” Mkt Perform” on Apr 21, 2016. AFLAC Incorporated was Upgraded by Macquarie to ” Outperform” on Apr 14, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 2, 2016 to “Sector Perform” and Lowered the Price Target to $ 64 from a previous price target of $66 .
AFLAC Incorporated opened for trading at $67.51 and hit $68.155 on the upside on Friday, eventually ending the session at $67.92, with a gain of 0.77% or 0.52 points. The heightened volatility saw the trading volume jump to 26,42,620 shares. Company has a market cap of $28,526 M.
In a different news, on Mar 21, 2016, Kriss Iii Cloninger (President) sold 16,000 shares at $63.62 per share price. According to the SEC, on Mar 15, 2016, Charles B Knapp (director) sold 4,000 shares at $61.63 per share price. On Mar 10, 2016, Hiroshi Yamauchi (President; Aflac Japan) sold 19,250 shares at $60.43 per share price, according to the Form-4 filing with the securities and exchange commission.
Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance which is marketed and administered through its subsidiary American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products including cancer plans medical indemnity plans medical/sickness riders care plans living benefit life plans ordinary life insurance plans and annuities. Aflac U.S. sells insurance products including products designed to protect individuals from depletion of assets such as accident cancer critical illness/care hospital intensive care hospital indemnity fixed-benefit dental and vision care plans and loss-of-income products.